MCL coexpression mm9:283

Phase1 CAGE Peaks

	Short description
Mm9::chr12:112910501..112910517,-	p1@Ckb
Mm9::chr12:120477061..120477075,-	p9@Itgb8
Mm9::chr12:120477090..120477107,-	p11@Itgb8
Mm9::chr12:81619544..81619562,+	p3@Galntl1
Mm9::chr13:58909624..58909647,+	p6@Ntrk2
Mm9::chr13:58910044..58910113,+	p2@Ntrk2
Mm9::chr14:26588278..26588288,-	p@chr14:26588278..26588288 -
Mm9::chr14:26588296..26588351,-	p2@Zcchc24
Mm9::chr15:81767125..81767146,-	p@chr15:81767125..81767146 -
Mm9::chr15:85408299..85408332,-	p2@Wnt7b
Mm9::chr16:91225654..91225671,+	p2@Olig2
Mm9::chr18:74023269..74023302,+	p2@Mro
Mm9::chr18:74023346..74023367,+	p3@Mro
Mm9::chr19:40439653..40439683,-	p@chr19:40439653..40439683 -
Mm9::chr1:137271513..137271523,-	p8@Shisa4
Mm9::chr2:25947296..25947311,-	p10@Nacc2
Mm9::chr2:25947351..25947375,-	p3@Nacc2
Mm9::chr2:25947434..25947443,-	p11@Nacc2
Mm9::chr2:25947453..25947479,-	p5@Nacc2
Mm9::chr2:25947481..25947508,-	p2@Nacc2
Mm9::chr2:25947538..25947553,-	p6@Nacc2
Mm9::chr2:25947568..25947579,-	p8@Nacc2
Mm9::chr5:138199361..138199441,+	p2@Tsc22d4
Mm9::chr7:125735998..125736019,+	p2@uc009jkd.1
Mm9::chr7:149558115..149558197,-	p1@6330512M04Rik
Mm9::chr7:149558226..149558241,-	p4@6330512M04Rik
Mm9::chr7:31077020..31077031,+	p10@Clip3
Mm9::chr7:4874446..4874498,+	p1@Nat14
Mm9::chr9:37175212..37175241,+	p1@Hepacam
Mm9::chr9:37175262..37175267,+	p@chr9:37175262..37175267 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:

---

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
ectodermal cell	2.40e-21	44
neurectodermal cell	2.40e-21	44
neural cell	1.11e-20	43
non-terminally differentiated cell	7.35e-18	49
neuron	1.29e-13	33
neuronal stem cell	1.29e-13	33
neuroblast	1.29e-13	33
electrically signaling cell	1.29e-13	33
CNS neuron (sensu Vertebrata)	1.94e-13	23
neuroblast (sensu Vertebrata)	1.94e-13	23
electrically responsive cell	2.86e-11	39
electrically active cell	2.86e-11	39
embryonic cell	6.61e-09	70
migratory neural crest cell	2.53e-08	10
neuron associated cell	2.53e-08	10
glial cell (sensu Vertebrata)	2.53e-08	10
neuron associated cell (sensu Vertebrata)	2.53e-08	10
glial cell	2.53e-08	10
glioblast	2.53e-08	10
glioblast (sensu Vertebrata)	2.53e-08	10
oligodendrocyte precursor cell	7.54e-08	8

Uber Anatomy

Ontology term	p-value	n
nervous system	1.09e-39	75
central nervous system	9.30e-39	73
ectoderm-derived structure	6.39e-37	95
ectoderm	6.39e-37	95
presumptive ectoderm	6.39e-37	95
regional part of nervous system	2.32e-30	54
neurectoderm	6.40e-29	64
neural plate	6.40e-29	64
presumptive neural plate	6.40e-29	64
neural tube	1.97e-28	52
neural rod	1.97e-28	52
future spinal cord	1.97e-28	52
neural keel	1.97e-28	52
ecto-epithelium	7.39e-27	73
brain	2.17e-24	47
future brain	2.17e-24	47
regional part of brain	1.37e-23	46
gray matter	2.30e-21	34
pre-chordal neural plate	1.74e-19	49
anterior neural tube	1.20e-18	40
regional part of forebrain	8.68e-18	39
forebrain	8.68e-18	39
future forebrain	8.68e-18	39
brain grey matter	1.05e-17	29
regional part of telencephalon	1.05e-17	29
telencephalon	1.05e-17	29
structure with developmental contribution from neural crest	7.51e-16	92
cerebral cortex	3.90e-12	21
cerebral hemisphere	3.90e-12	21
pallium	3.90e-12	21
regional part of cerebral cortex	1.01e-10	17
posterior neural tube	1.53e-10	12
chordal neural plate	1.53e-10	12
occipital lobe	3.67e-08	10
visual cortex	3.67e-08	10
neocortex	3.67e-08	10
basal ganglion	7.43e-07	8
nuclear complex of neuraxis	7.43e-07	8
aggregate regional part of brain	7.43e-07	8
collection of basal ganglia	7.43e-07	8
cerebral subcortex	7.43e-07	8

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}